0 Ratings
ID

13048

Description

Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.; ODM derived from: https://clinicaltrials.gov/show/NCT00502034

Link

https://clinicaltrials.gov/show/NCT00502034

Keywords

Versions (1)
  1. 1/13/16 1/13/16 -
Uploaded on

January 13, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Carcinoma, Renal Cell NCT00502034

    English

    Eligibility Carcinoma, Renal Cell NCT00502034

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    diagnosis histologically confirmed of renal cells carcinoma (every histotype);
    Description

    renal cell carcinoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0007134
    age < 75 years
    Description

    Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    radical surgical removal of the tumor: total or partial nephrectomy within previous 3 months
    Description

    surgery, total/partial nephrectomy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0038894
    UMLS CUI [2]
    C0027695
    patient classified as t1 (with diameter > 2,5 cm), t2, t3 a-b-c; in presence of involvement of loco-regional lymph-nodes (staging n1, n2, n3, tnm class.), metastases should have been completely removed during nephrectomy
    Description

    tumor stage, metastases

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1300072
    UMLS CUI [2]
    C0027627
    absence of distant metastases;
    Description

    distant metastases

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0027627
    written informed consent
    Description

    written informed consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    tumor diameter equal or less than 2,5 cm;
    Description

    tumor diameter

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0475440
    UMLS CUI [2]
    C3272927
    previous chemotherapy or ormonotherapy o immunotherapy;
    Description

    chemotherapy, hormone therapy or immunotherapy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C0279025
    UMLS CUI [3]
    C0021083
    renal insufficiency >3 mg/dl);
    Description

    renal insufficiency, creatinine

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1565489
    UMLS CUI [2]
    C0201976
    no symptomatic arrhythmias or autoimmune disease
    Description

    arrhythmias, autoimmune diseases

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0003811
    UMLS CUI [2]
    C0004364
    Back to the top of the page

    Similar models

    Eligibility Carcinoma, Renal Cell NCT00502034

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    renal cell carcinoma
    Item
    diagnosis histologically confirmed of renal cells carcinoma (every histotype);
    boolean
    C0007134 (UMLS CUI [1])
    Age
    Item
    age < 75 years
    boolean
    C0001779 (UMLS CUI [1])
    surgery, total/partial nephrectomy
    Item
    radical surgical removal of the tumor: total or partial nephrectomy within previous 3 months
    boolean
    C0038894 (UMLS CUI [1])
    C0027695 (UMLS CUI [2])
    tumor stage, metastases
    Item
    patient classified as t1 (with diameter > 2,5 cm), t2, t3 a-b-c; in presence of involvement of loco-regional lymph-nodes (staging n1, n2, n3, tnm class.), metastases should have been completely removed during nephrectomy
    boolean
    C1300072 (UMLS CUI [1])
    C0027627 (UMLS CUI [2])
    distant metastases
    Item
    absence of distant metastases;
    boolean
    C0027627 (UMLS CUI [1])
    written informed consent
    Item
    written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    tumor diameter
    Item
    tumor diameter equal or less than 2,5 cm;
    boolean
    C0475440 (UMLS CUI [1])
    C3272927 (UMLS CUI [2])
    chemotherapy, hormone therapy or immunotherapy
    Item
    previous chemotherapy or ormonotherapy o immunotherapy;
    boolean
    C0392920 (UMLS CUI [1])
    C0279025 (UMLS CUI [2])
    C0021083 (UMLS CUI [3])
    renal insufficiency, creatinine
    Item
    renal insufficiency >3 mg/dl);
    boolean
    C1565489 (UMLS CUI [1])
    C0201976 (UMLS CUI [2])
    arrhythmias, autoimmune diseases
    Item
    no symptomatic arrhythmias or autoimmune disease
    boolean
    C0003811 (UMLS CUI [1])
    C0004364 (UMLS CUI [2])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial